Jacqueline McCluskey

Title: Jacqueline McCluskey: Innovator in Immunology

Introduction

Jacqueline McCluskey is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines and therapeutic compositions. With a total of 2 patents, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents is for a Meningococcal B recombinant vaccine. This immunogenic composition comprises a combination of meningococcal antigens, including at least one factor H binding protein (fHBP) A protein, at least one fHBP B protein, at least one adhesin A (NadA) protein, and at least one detergent-extracted Outer Membrane Vesicle (dOMV). The combination of these antigens provides broad coverage of bacteria strains, and the patent also discusses methods for eliciting an immune response using this composition. Another significant patent involves Porphyromonas gingivalis polypeptides, which includes compositions and methods for eliciting an immune response against periodontitis. This patent outlines polypeptides, fragments, and variants that are useful in the diagnosis, prevention, and therapy of infections, along with methods for detection and treatment.

Career Highlights

Jacqueline McCluskey is currently employed at Sanofi Pasteur Inc., where she continues to advance her research in immunology. Her work is crucial in developing innovative solutions to combat infectious diseases.

Collaborations

Some of her notable coworkers include Laurence Quemeneur and Nadège Arnaud-Barbe, who contribute to her research efforts and innovations.

Conclusion

Jacqueline McCluskey's contributions to immunology through her patents and work at Sanofi Pasteur Inc. highlight her role as a leading inventor in the field. Her innovative approaches to vaccine development and infection treatment are paving the way for advancements in public health.